GMC number: 6145675
Year of first qualification: 2006, University of Bristol
Specialty: Gastroenterology, Hepatology, Endoscopy
Clinical interest: Hepatology, General Gastroenterology including Functional and Inflammatory Bowel Disease, Endoscopy
Secretary: Jana Mickova
Tel: 0117 4146499
Dr Ankur Srivastava graduated from the University of Bristol in 2006 and completed his specialist training in London. He participated in doctoral (PhD) studies at the University College London, with whom he maintains an affiliation, and the Royal Free liver transplant unit with a focus on earlier detection of chronic liver disease.
Dr Srivastava is a GMC registered gastroenterologist and hepatologist with interests in inflammatory bowel disease, liver transplant medicine and advanced hepatology. Dr Srivastava returned to Bristol as a consultant in 2018. He is a general gastroenterologist, hepatologist and endoscopist working in a large multi-disciplinary team. He has a sub-specialist interest in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. He is a member of the BASL NAFLD special interest group (SIG). The department has developed close links with Kings College London liver transplant unit with the majority of pre- and post- transplant care conducted in North Bristol.
Dr Srivastava is leading the trusts accreditation in the Royal College of Physicians ‘Improving Quality in Liver Services” process. This is a national quality improvement project to document and improve all aspects of patient care including leadership and operational delivery, clinical effectiveness and involving patients in service development. He has also helped develop a rapid access clinic for patients suffering significant flares of their inflammatory bowel disease.
Dr Srivastava is the research lead for Gastroenterology at the trust with an expanding and diverse research portfolio. Dr Srivastava is principle investigator at the trust for a commercial drug trial for patients with NAFLD. He is sub-investigator for a number of trials in inflammatory bowel disease, liver disease and endoscopy and has published over 5 peer reviewed journal articles in the past few years.